Naturally occurring regulatory T cells (Treg) express high levels of glucocorticoid-induced tumour necrosis factor receptor (GITR). However, studies of the role of GITR in Treg biology has been complicated by the observation that upon activation effector CD4 1 T (Teff) cells also express the receptor. Here, we dissect the contribution of GITR-induced signaling networks in the expansion and function of FoxP3
Introduction
The immune system has the ability to distinguish self from nonself, which enables it to remove foreign antigens without inducing autoimmunity. Deletion of most self-reactive T-cell clones occurs during development in the thymus and is known as central tolerance. However, because some selfreactive T cells escape this selection process, peripheral tolerance mechanisms are required to effectively prevent autoimmune diseases. Naturally occurring CD4 + CD25 + Treg cells represent one of the best documented systems governing peripheral suppression of CD4 + and CD8 + T cells (1, 2) . Regulatory T cells (Treg) suppress T cell-induced diseases in animal models of inflammatory bowel diseases (3) (4) (5) , experimental autoimmune encephalomyelitis (EAE) (6) (7) (8) , autoimmune myocarditis and skeletal muscle myositis (9) , and graft-versus-host disease (10, 11) , which confirm their regulatory function of adaptive immune responses. These cells have been shown to proliferate in vivo, as judged in a cotransfer model with disease-inducing T cells (12, 13) .
A variety of different mechanisms have been suggested for Treg-mediated suppressive function (14) .
The transcription factor FoxP3 controls the development of naturally occurring Treg, as demonstrated in patients with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome or in scurfy mutant mice that lack a functional FoxP3 gene and consequently Treg (15) (16) (17) . Additional evidence is provided by data showing that ectopic expression of FoxP3 by retroviral gene transfer into CD4 + CD25 À cells endows them with suppressor functions (16) . Neither naive nor activated CD4 + CD25 À T cells express FoxP3, rendering expression of this transcription factor the most specific marker for Treg in contrast to CD25, glucocorticoid-induced tumour necrosis factor receptor (GITR) or cytotoxic T-lymphocyte antigen-4, all of which can be expressed in activated CD4 + CD25 À T cells. FoxP3 + Treg are not only generated in the thymus (18) but have also been reported to be inducible in the peripheral organs under specific conditions (19, 20) .
The GITR-related gene is a member of the tumor necrosis factor (TNF) receptor superfamily (TNFRSF18). This gene was first cloned from a murine T-cell hybridoma as a dexamethasone-inducible molecule (21) . GITR is highly expressed on naturally occurring CD4 + CD25 + Treg. However, GITR is also expressed at lower levels on the surface of naive T cells, but its expression is up-regulated after activation (5) . Its ligand, GITR ligand (GITR-L, TNFSF18), was cloned from both human and mouse cells by several groups (22) (23) (24) (25) . Mouse GITR-L is expressed at low levels in nonstimulated B cells and bone marrow-derived dendritic cells (BMDCs) and is transiently inducible by LPS (23, 25) . Recent structural analyses reveal that unlike human GITR-L and other TNF family members, mouse GITR-L assembles into a functional dimer, which renders its structural and biomedical properties unique within the members of the TNF and TNFRSFs, which form trimers (26, 27) .
Administration of aGITR mAb not only abrogates Tregmediated suppression of CD4 + CD25 À effector CD4 + T cells (Teff) in vitro but it also breaks immunological tolerance against self-antigen and some types of progressive tumor cells in vivo (5, 24, 25, 28, 29) . How GITR ligation regulates T cell-mediated autoimmunity in vivo and what the consequences of GITR-GITR-L interactions are for Treg functions are generally not well understood. In experiments using cocultures of CD4 + CD25 + Treg and CD4 + CD25 À Teff with irradiated antigen-presenting cells (APC), anti-GITR was shown to reduce the suppressive capability of Treg (5). Similar results were also observed using a soluble GITR-L (24) . By contrast, a second group using a similar system, but replacing the mAb with a GITR-L-expressing cell line, found that Teff became refractory to Treg-mediated suppression (25) .
In an attempt to further elucidate the mechanisms by which GITR signaling regulates T cell-mediated immune responses, we used an Fc-GITR-L fusion protein together with CD4
+ T-cell subsets derived from either wild type (wt) or GITR À/À mice and an in vitro system in which magnetic beads are coupled with aCD3e. Our results indicate that ligation of the co-stimulatory molecule GITR by its soluble ligand induces the in vitro and in vivo proliferation of CD4 + CD25 + FoxP3 + Treg. The suppressive activity of Treg remains high in the presence of Fc-GITR-L in cocultures or after the in vitro expansion of isolated FoxP3 + Treg. In a gene therapy mouse model, when human coagulation factor (hF.IX) gene was forcefully expressed in C3H/HeJ hemophilia B mice by an adeno-associated virus (AAV) vector, combined treatment of Fc-GITR-L enhanced the human coagulation factor IX (hF.IX) level and inhibited the production of anti-coagulation factors. Taken together, the results indicate that GITR ligation differentially governs immune responses by T-cell subsets and that the preferential induction of Treg makes GITR signaling more pro-tolerant than pro-inflammatory.
Methods

Mice
Pathogen-free B6129SF1 mice were obtained from JaxMice (Bar Harbor, ME, USA). GITR À/À mice were provided by Drs C. Riccardi and P. P. Pandolfi (30) . Generation of the FoxP3-IRES-EGFP knock-in mice was described previously (31) . FoxP3-IRES-EGFP knock-in C57BL/6 mice were generously provided by Dr V. Kuchroo (32) . These animals were housed in the new research building animal facility of Harvard Medical School. The experiments were performed according to the guidelines of Institutional Animal Care and Use Committee at Beth Israel Deaconess Medical Center and Harvard. Hemophilia B mice carrying an F9 gene deletion had been repeatedly backcrossed onto C3H/HeJ background (>10 generations) prior to experiments (33) . Experiments in hemophilia B mice were in accordance with protocols approved by Institutional Animal Care and Use Committee at the University of Florida, Gainesville.
cytomegalovirus promoter in expression vector pCDNA4/ myc-HisC from Invitrogen. The j light chain leader sequence (5#ATGGAGACAGACACACTCCTGCTATGGGTACTGCTGCTC TGGGTTCCAGGTTCCACTGGTGA3#) was introduced in front of the hIgG1 Fc fragment for helping the secretion of the fusion protein. 293F cells transfected with the plasmid expressing Fc-GITR-L were selected with zeocin for stable cell lines. Stable Fc-GITR-L-expressing cells were cultured in Corning spin bottles, and Fc-GITR-L fusion protein was purified with a protein G agarose bead column from the supernatant. Purified Fc-GITR-L fusion protein was typically >95% pure by Coomassie blue staining analysis.
Coupling aCD3e to MACSi Beads
Ten micrograms of biotin-aCD3 antibody was diluted to 500 ll with 13 PBS supplemented with 2 mM of EDTA and 5% of BSA; then the diluted antibody was mixed with 500 ll of anti-biotin MACSi Bead (1 3 10 8 particles) (Miltenyi Biotec Inc., Auburn, AL, USA) and rotated at 4°C for 2 h. Anti-CD3 beads were washed with RPMI medium (RPMI 1640 supplemented with 10% FCS, 100 U ml À1 of penicillin, 100 lg ml À1 of streptomycin, 2 mM of L-glutamine, 1 mM of sodium pyruvate and 50 lM of b-mercaptoethanol) before being used for T-cell activation.
In vitro CD4 + T-cell expansion ) in the presence of IL-2 (10 ng ml À1 ) for 1, 2, 3, or 4 days. Total live cell number was counted manually using 0.4% trypan blue under the microscope, which was then normalized to the initial number for the fold of proliferation. To determine the frequency of FoxP3-and CD25-expressing cells, cells were stained with PerCP-aCD4 and PE-aCD25 and DAPI. DAPI-negative cells representing the live cells were gated to analyze the frequency of CD4 + , GFP + (FoxP3 + ) and CD25 + cells.
Flow cytometry analysis
For analyzing the expression of cell surface molecules, the BD LSRII Flow Cytometer was used to collect flow cytometric data and analyzed with FlowJo Software. 
Generation of BMDCs
Bone marrow cells were flushed from the femurs and tibias; 2 3 10 6 bone marrow cells were cultured in 10 ml of RPMI 1640 medium supplemented with 20 ng ml À1 of rGM-CSF and 20 ng ml À1 of rIL-4. Fresh medium was added in the culture on days 3 and 6. Non-adherent cells were used for activating CD4 + CD25 + Treg.
Immunoblotting assay
Both wt and GITR À/À CD4 + CD25 + Treg were pre-activated with 1 lg ml À1 of soluble aCD3e in the presence of BMDCs for 48 h. Then, BMDCs were depleted with CD11C + DC isolation kit (Miltenyi Biotec Inc.) and aCD3e was washed off. After resting for 24 h in the presence of 10 ng ml À1 of rIL-2, cells were washed once with fresh RPMI medium and re-activated with aCD3e in the presence or absence of Fc-GITR-L for 1 h. Whole-cell lysates were prepared by lysing the cells with RIPA buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl; 1% Nonidet P-40; 0.5% sodium deoxycholate; 1 mM EDTA; 1 mM phenylmethylsulfonyl fluoride; 1 mM dithiothreitol and one-hundredth volume of a protease inhibitor mixture) as described before (34) . Cell lysates were separated by SDS-PAGE and subjected to immunoblot using the indicated antibodies. Fc-GITR-L 4 days before thymus, spleen and mesenteric lymph node (MLN) were excised from the mice. Total cell numbers were counted using trypan blue. CD4 + FoxP3 + frequencies were evaluated by FACS.
In vivo administration of Fc-GITR-L to FoxP3-IRES-GFP mice
AAV vector preparation
AAV vector expresses hF.IX from the hepatocyte-specific ApoE enhancer/hepatocyte control region and human a 1 -antitrypsin promoter were as published (35) . The expression cassette is flanked by AAV-2 inverted terminal repeats. AAV vectors (serotype 2) were produced by triple transfection of HEK-293 cells, purified by CsCl gradient centrifugation, filter-sterilized, and quantified by slot blot hybridization using standard protocols.
Suppression of immune response to hF.IX in hemophilia B mice
Fc-GITR-L (200 lg per mouse per dose) was injected intraperitoneally into hemophilia B (C3H/HeJ F9 À/À ) mice for a total of seven doses (given 3-4 days apart over a period of 1 month). After four injections, AAV-hF.IX (serotype 2, 1 3 10 11 vector genome per mice) was administered via the portal vein. Levels of hF.IX antigen in plasma samples were measured by hF.IX-specific ELISA. Inhibitory antibodies to hF.IX were measured by the Bethesda assay, and activated partial thromboplastin time of plasma samples was measured using a fibrometer as published (33) .
Statistical analysis
All data with statistical analysis were graphed and compared for significance using a two-tailed Student's t-test with Prism 4 for Macintosh, Version 4.0c (GraphPad Software, Inc.).
Results
Engagement by Fc-GITR-L differentially induces proliferation of Treg and Teff
A purified Fc-GITR-L fusion protein generated in 293T cells with a molecular weight of 40 kD under reducing conditions and 92 kD under non-reducing conditions (Supplementary Figure S1A and S1B, available at International Immunology Online) was used for these studies. The molecular weight indicates that the disulfide bond in the hinge of the human Fc fragment dimerizes the fusion protein and that Fc-GITR-L is a dimer. This is a natural configuration of GITR-L as structural analyses show that mouse GITR-L forms a non-disulfidebonded dimer (26, 27, 36) . Thus, the soluble dimer of GITR-L specifically interacts with GITR.
Next, Fc-GITR-L was used to further define the role of GITR as a co-stimulatory molecule on the surface of Treg. To this end, CD4 + CD25 + FoxP3 + cells were purified from the spleens of FoxP3-IRES-EGFP knock-in mice, either on the C57BL/6 or on the BALB/c background (31, 32) . Cells were stimulated with combinations of Fc-GITR-L, IL-2 and aCD3e and expansion was followed for 4 days by cell counting and flow cytometry. On day 3 of activation of FoxP3 + Treg with Fc-GITR-L, IL-2 and aCD3e, proliferation became detectable and at day 4, the total cell number had increased by ;11 times. In the presence of Fc-GITR-L, cells proliferated three times more than when incubated with aCD3 and IL-2. The number of FoxP3 + Treg only doubled upon culturing in the presence of combinations of IL-2 and aCD3e or IL-2 and Fc-GITR-L (Fig. 1A) (37) . Fc-GITR-L, IL-2 and aCD3e stimulated cells expressing high levels of FoxP3 and CD25 indicating a stable phenotype (Fig. 1B) . Importantly, the expanded FoxP3 + Treg suppressed proliferation of CD4 + CD25 À Teff as effectively as freshly isolated FoxP3
+ Treg (Fig. 1C) .
Proliferation of CD4
+ CD25 À FoxP3 À Teff with Fc-GITR-L, IL-2 and aCD3e was 1.5 times that of proliferation in the presence of IL-2 and aCD3e ( Fig. 2A) . Stimulation with IL-2 and aCD3e of CD4 + CD25
À
FoxP3
À Teff resulted in a much faster proliferation than that of Treg ( Fig. 2A) . The Teff number was significantly reduced in the presence of IL-2 alone, most likely due to the lack of CD25 expression in their surface. Importantly, the Teff cells did not convert to FoxP3
+ upon stimulation under these conditions (Fig. 2B) . Taken together, the data show that Fc-GITR-L in concert with IL-2 and aCD3e induces proliferation of all CD4 + cells. FoxP3 + cells, however, react stronger than FoxP3 À cells to ligation of GITR.
Fc-GITR-L provides a co-stimulatory signal for proliferation of Treg
To further define the role of GITR as a co-stimulatory molecule on the surface of Treg, the IL-2 dependence was quantitated in [ 3 H]-thymidine uptake assays. To this end, CD4 + CD25 + cells purified from the spleens of wt mice were stimulated with aCD3e-coupled beads in the presence or absence of Fc-GITR-L and increasing concentrations of IL-2. In the presence of 7 ng ml À1 of IL-2, aCD3e-coupled beads and Fc-GITR-L induced the highest level of proliferation of wt natural Treg (Fig. 3A) . In the absence of aCD3, Fc-GITR-L and IL-2 induced a substantial activation (Fig. 3A) . Conversely, in the absence of IL-2, a combination of aCD3e-coupled beads and 1 lg Fc-GITR-L induced a low level of proliferation of wt Treg, while control GITR À/À Treg do not respond (Fig. 3B ). When the same Treg were re-stimulated with a combination of Fc-GITR-L and aCD3e, IjBa was almost completely degraded after 1 h (Fig. 3C ). This suggests a rapid activation of the canonical NF-jB pathway by engagement of GITR, consistent with our other observations (24, 38) . 
CD25
À Teff. It was hypothesized that this could be caused either by abrogating Treg-mediated suppression or by rendering the Teff resistant to Treg (5, 24, 25) . These interpretations contrasted with our observations in Fig. 1 , which indicate that expansion of Treg in the presence of Fc-GITR-L did not abrogate the suppressor function of Treg. To further rule out that a continuous ligation of GITR molecules could attenuate Treg suppression, we cocultured Treg and Teff purified from either wt or GITR À/À mice. Combinations of wt and GITR À/À Treg and Teff were then activated with aCD3-beads in the presence or absence of Fc-GITR-L and suppression was assessed by IL-2 production, [ 3 H]-thymidine uptake or CFSE dilution (2, 25, 39) .
When IL-2 secretion by GITR À/À Teff induced by aCD3-beads was used as the readout for suppressor activity, both wt and GITR À/À Treg suppressed equally well (Fig. 4A, right panel) . Furthermore, when Fc-GITR-L was added to the cocultures of Teff and Treg, suppression was not abrogated. However, when (Fig. 4C, right panel) , we concluded that Fc-GITR-L did not abrogate Treg suppression.
Fc-GITR-L does not render Teff refractory to Treg suppression
We next determined whether Fc-GITR-L-induced triggering of GITR on wt Teff rendered them refractory to Treg suppression. To address this question, cocultures of wt Teff with either wt or GITR À/À Treg were activated with aCD3-beads in the presence or in the absence of Fc-GITR-L and suppression was assessed by IL-2 production, [
3 H]-thymidine uptake or CFSE.
When IL-2 production by wt Teff was used as the readout for suppression activity, both wt and GITR À/À Treg suppressed equally well (Fig. 5A, right panel) in the absence of Fc-GITR-L. The IL-2 production by wt Teff increased by about five times in the presence of Fc-GITR-L (Fig. 5A, left  panel) , suggesting that Fc-GITR-L ligation of GITR on wt Teff triggers a strong activation of transcription and/or translation of the IL-2 gene, consistent with previous reports (40) . Fc-GITR-L-induced IL-2 production by wt Teff was significantly inhibited by both wt and GITR À/À Treg (Fig. 5A, left  panel) . Fc-GITR-L-induced IL-2 levels in cocultures of wt Teff and wt Treg were lower than that in wt Teff and GITR À/À Treg, suggesting that GITR ligation on Treg makes them more suppressive (Fig. 5A, left panel) .
When [ 3 H]-thymidine uptake was used as the readout, the proliferation of wt Teff was equally well suppressed by both wt and GITR À/À Treg (Fig. 5B, right panel) , consistent with the IL-2 production assay (Fig. 5A, right panel) . Fc-GITR-L significantly induced the [ 3 H]-thymidine uptake by wt Teff when Treg were not added (Fig. 5B, left panel) . Fc-GITR-Linduced [ 3 H]-thymidine uptake by wt Teff was inhibited by GITR À/À Treg (Fig. 5B, left panel) , indicating that Fc-GITR-L ligation on wt Teff alone did not make them refractory to in vitro suppression by GITR À/À Treg. Although Fc-GITR-Linduced [ 3 H]-thymidine uptake in coculture of wt Teff and wt Treg was higher than that in coculture of wt Teff and GITR À/À Treg, it was 40% lower than that of wt Teff alone (Fig. 5B, left panel) , suggesting that triggering of GITR by Fc-GITR-L on both wt Teff and wt Treg may not cause proliferation of wt Teff cells.
The notion that wt Teff had not become refractory to suppression upon engagement with Fc-GITR-L was also supported by our CFSE dilution assay. FACS-purified wt Teff and wt Treg, in which one of the subsets was labeled with CFSE, were cocultured at 8:1 ratio and activated with aCD3-beads in the presence or in the absence of Fc-GITR-L for 3 days. As shown in (Fig. 5C) (left panel) , Fc-GITR-L induced the proliferation of CFSE-labeled wt Treg in coculture with unlabeled wt Teff. This demonstrated a direct effect on wt Treg proliferation, consistent with the results in Figs 1-4 . Because Fc-GITR-L did not induce the proliferation of CFSE-labeled wt Teff in coculture with unlabeled wt Treg (Fig. 5C, right panel) , we conclude that Fc-GITR-L ligation on wt Teff does not allow them to escape the suppression by wt Treg.
Taken together, neither suppression by Treg nor susceptibility by Teff is diminished after engagement of GITR and Fc-GITR-L co-stimulation preferentially induced the proliferation of Treg.
In vivo administration of Fc-GITR-L induces proliferation of CD4 + FoxP3 + Treg but not CD4 + FoxP3 À Teff
As mentioned above, ligation of GITR induces stronger proliferation of functionally competent Treg in vitro. In order to study whether this represents the physiological function of GITR signaling in vivo, we injected Fc-GITR-L intraperitoneally into FoxP3-IRES-EGFP knock-in mice of C57BL/6 background (every 3-4 days for 2 or 4 weeks) in the absence of exogenous antigenic stimulation. The percentages of CD4 + FoxP3 + Treg were significantly increased in the thymus and spleen after 2 weeks of Fc-GITR-L administration (Fig. 6A) . After 4 weeks of continuous administration of Fc-GITR-L, the frequencies of CD4 + FoxP3 + Treg were significantly induced in the thymus, spleen and MLN (Fig. 6B) . However, the absolute numbers of CD4 + T cells in the thymus, spleen and MLN were not significantly increased by ei- 
develops in F9
À/À mice of C3H/HeJ background (41, 42) . A recent detailed analysis demonstrated that systemic hF.IX expression in this strain is limited by CD8 + T-cell response that eliminates a portion of hF.IX-expressing hepatocytes and, by formation of inhibitory antibodies (inhibitors), albeit that this immune response is substantially weaker compared with other routes of antigen administration/expression (33) . Here, we tested whether the induction of CD4 
FoxP3
+ Treg by in vivo Fc-GITR-L administration could suppress the response, thereby augmenting therapy, in this strain of hemophilia B mice. Consistent with our previous findings (33), C3H/HeJ F9 À/À mice expressed only low levels of hF.IX following gene transfer and developed inhibitors of 4-11 Bethesda unit (BU) by 3 months (Fig. 7A and data not  shown) . In contrast, administration of Fc-GITR-L (every 3-4 days for 4 weeks) combined with gene transfer (which was performed after the fourth Fc-GITR-L injection) directed substantially higher levels of hF.IX expression at 1-and 2-month time points (Fig. 7A) . However, expression decreased to the low levels seen in control mice by 3 months (Fig. 7A) . In agreement with these data, coagulation times were most shortened by 2 months, i.e. the peak of hF.IX expression, but then gradually increased. As shown in (Fig. 7B) , the coagulation time was normally >60 s in untreated F9
À/À mice and ;25-35 s in wt mice (42) . The control mice that only received hF.IX gene transfer had marginal correction because of low-level expression (just <60 s on average). The mice that received hF.IX gene transfer and Fc-GITR-L administration had at least initially a more substantial correction. The coagulation time was ;45 s at the second month, which was the shortest during the whole process, consistent with the hF.IX ELISA levels. Somehow, the effect was transient, and hF.IX levels and clotting times were similar for both groups at late time points. Antibodies against hF.IX were only formed by 5-6 months in 4 of 5 mice (1-1.6 lg ml À1 serum), resulting in low-titer inhibitors of 2-3 BU in 2 of 5 mice by 6 months (data not shown).
Discussion
In an effort to dissect the influence of GITR signaling on the regulation of immune responses, we produced a fusion protein composed of the extracellular domain of mouse GITR-L instead of using the aGITR mAb. We expected that GITR ligation with Fc-GITR-L would represent the natural condition better than ligation with an mAb and would have a longer in vivo life span than the soluble form of GITR-L that was previously published (24) . In order to eliminate the need for 
Treg. Both wt and GITR
À/À Treg were pre-activated with 1 lg ml À1 of soluble aCD3e in the presence of BMDCs for 2 days. After resting for 24 h by depleting the BMDCs and washing off the aCD3e, cells were re-activated with aCD3e and Fc-GITR-L for 1 h. Cell lysates were separated by SDS-PAGE and immunoblotted with anti-IjBa. The same membrane was reprobed with anti-b-actin as a loading control. The data are representative of at least three independent experiments. Statistical significance was determined by the two-tailed Student's t-test. *P < 0.05; **P < 0.01; ***P < 0.005.
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other co-stimulatory molecules, aCD3e-conjugated beads were used as APC surrogates, allowing us to focus on the influence of GITR signaling on T-cell responses. Consistent with previous studies (5, 24, 25, 30) , our results confirm that GITR functions as a co-activator for both Teff and Treg when they are cultured separately. GITR ligation does not induce the conversion between The data from both the in vitro proliferation and suppression assays and the AAV-hF.IX gene transfer mouse model strongly argue that GITR signaling in vivo is more likely to enhance rather than break immune tolerance. van Olffen et al. (40) reported that the number of Treg is significantly increased in a CD19 promoter-driven GITR-L transgenic (Tg) mice model. Consistent with the increased number and frequency of Treg, the GITR-L Tg mice show delayed onset of EAE induction and milder disease activity scores.
In support of this notion, Fc-GITR-L co-stimulation triggers significant induction of IL-2 production by wt Teff cells (Fig. 5A) . It has been well accepted that IL-2 is important for the hematopoiesis and function of Treg. Mice lacking ) and CD4 + CD25 + Treg (wt) were purified by FACS and stained with CFSE. GITR À/À Teff and wt Treg (with or without CFSE) were mixed at 8:1 ratio and stimulated with aCD3-bead in the presence or absence of Fc-GITR-L. Three days later, CFSE-positive cells were gated for evaluating cell proliferation. The data, presented as mean 6 SEM, are representative of three independent experiments. Statistical significance was determined by the two-tailed Student's t-test. **P < 0.01. IL-2 or components of the IL-2 receptor (IL-2Ra and IL-2Rb) succumb to an aggressive lymphoproliferation and severe autoimmune symptoms (43) (44) (45) . Fc-GITR-L-induced IL-2 production by Teff cells may cause the increased Treg frequency in vivo. GITR À/À mice, however, have normal FoxP3 + Treg numbers (data not shown) and show no sign of autoimmune diseases, suggesting that GITR is dispensable for IL-2 production. The concept that GITR signaling might break immune tolerance was based on the application of a widely used anti-GITR (DTA-1) mAb generated by Dr Sakaguchi's laboratory. We also compared the functional activity between Fc-GITR-L fusion protein and DTA-1. Both of them show a similar costimulatory ability in inducing the proliferation of Teff and Treg by an in vitro assay (data not shown). In contrast to the increasing FoxP3 + Treg in the presence of Fc-GITR-L, in vivo administration of DTA-1 results in a decreased FoxP3 + Treg percentage in two different models, which ultimately breaks the tolerance and induces the immune response (5, 46) . These results suggest that the mAb DTA-1 and Fc-GITR-L may behave differently in vivo due to their differential affinities to the mouse complementary system. Application of DTA-1 may partially deplete the FoxP3 + Treg before the expansion of this population, which activates the immune response against cancer or exogenous protein. Alternatively, Fc-GITR-L can relay a positive signal to induce proliferation of functionally competent Treg rather than cause their depletion, which may be applied for the induction of tolerance.
GITR-L is present on a variety of cells, including B cells, mature and immature dendritic cells (DCs) (23, 25) . The expression of GITR is also not only confined to T cells (47) . The abundant expression pattern and the bidirectional communication utilized by GITR-L-GITR interaction will undoubtedly increase the complexity for the investigation of GITR function. Administration of Fc-GITR-L may also block the reverse signaling through GITR-L in plasmacytoid DCs, which was reported to activate an indoleamine-2,3-dioxygenasedependent pathway to inhibit immune response in an allergy model (48) . If administering Fc-GITR-L just blocks the reverse signaling through GITR-L in plasmacytoid dendritic cell, it should induce an immune response rather than induce tolerance against the liver-expressed hF.IX by AAV-2 vector in the C3H/HeJ F9 À/À strain. So, it is most likely that signaling through GITR, but not though GITR-L, causes the expansion of CD4 + FoxP3 + Treg and the subsequent tolerance induction. Taken together, the results clearly argue the hypothesis that GITR ligation on Teff and/or Treg with GITR expression induces Teff cell proliferation and breaks immune tolerance to foreign antigens. In contrast, GITR ligation preferentially causes the expansion of Treg both in vitro as well as in vivo without breaching their suppressive capability, which may be applied for tolerance induction although the conditions need to be optimized. FACS-purified wt Teff and wt Treg, in which one of the subset was labeled with CFSE, were cocultured at 8:1 ratio. After a 3-day activation with aCD3-bead with or without Fc-GITR-L, CFSE-positive cells were gated for evaluating cell proliferation. The data, presented as mean 6 SEM, are representative of more than three independent experiments. Statistical significance was determined by the two-tailed Student's t-test. ns, P > 0.05; *P < 0.05; **P < 0.01; ****P < 0.001.
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FoxP3
+ Treg frequencies were evaluated by FACS. Each filled or open circle represents one mouse treated with IgG control or Fc-GITR-L, respectively. Statistical significance was determined by the two-tailed Student's t-test. ns, P > 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001. À/À mice. Blood was collected from C3H/HeJ F9 À/À mice that received hepatic gene transfer alone with the AAV-hF.IX vector (filled squares, n = 6) or combined gene transfer with Fc-GITR-L administration (filled diamonds, n = 5) at different time points. Activated partial thromboplastin time (aPPT) of plasma samples was measured using a fibrometer. The data are represented as mean 6 SEM. Statistical significance was determined by the two-tailed Student's t-test. **P < 0.01.
